tiprankstipranks
Advertisement

DTAN - ETF AI Analysis

Compare

Top Page

DTAN

Sparkline International Intangible Value ETF (DTAN)

Rating:67Neutral
Price Target:
DTAN’s overall rating suggests it is a solid but not top-tier ETF, supported by high-quality global companies. Strong holdings like Novartis, Toyota, and AstraZeneca, which show robust financial health, positive earnings commentary, and generally supportive valuations or technical trends, help lift the fund’s quality. However, some positions such as SAP and L’Oreal face issues like bearish or mixed technical signals and potential overvaluation, and the fund’s notable tilt toward large pharmaceutical and healthcare names means performance is somewhat exposed to risks in that sector.
Positive Factors
Broad International Diversification
The fund spreads its investments across many countries in Europe, Asia, and North America, which can help reduce the impact of problems in any single market.
Mix of Defensive and Growth Sectors
Significant exposure to health care, consumer companies, and technology provides a balance of more stable businesses and growth-oriented firms.
Several Strong Top Holdings
Some of the largest positions, such as Novartis, Siemens, L’Oreal, and Shell, have shown strong recent performance, supporting the ETF’s overall returns.
Negative Factors
Moderate Expense Ratio
The fund’s fee is not especially low, which means a noticeable portion of returns goes toward covering costs each year.
Multiple Weak Top Holdings
Several major positions, including Toyota, AstraZeneca, SAP, Sanofi, and Sony, have recently lagged, which can drag on the ETF’s performance.
Concentrated in a Few Countries
A large share of assets is tied up in Japan, Germany, and the U.S., so setbacks in these markets could have an outsized effect on the fund.

DTAN vs. SPDR S&P 500 ETF (SPY)

DTAN Summary

Sparkline International Intangible Value ETF (DTAN) is an international stock fund that focuses on companies whose value comes largely from things you can’t touch, like strong brands, patents, and research. It doesn’t track a single index, but follows a theme of “intangible value” across many countries, with big names like Toyota and Sony among its holdings. Investors might consider DTAN for global diversification and potential long-term growth from innovative, brand‑driven businesses. A key risk is that the share price can rise or fall with global stock markets and the fund’s focus on this specific style may underperform at times.
How much will it cost me?The Sparkline International Intangible Value ETF (DTAN) has an expense ratio of 0.55%, meaning you’ll pay $5.50 per year for every $1,000 invested. This is slightly higher than average because the fund is actively managed, focusing on companies with strong intangible assets, which requires more research and expertise.
What would affect this ETF?The Sparkline International Intangible Value ETF (DTAN) could benefit from global economic growth and increased demand for innovative companies leveraging intangible assets, such as intellectual property and brand strength, particularly in sectors like Health Care and Technology. However, it may face challenges from rising interest rates, which can impact the valuation of growth-focused companies, and geopolitical tensions or regulatory changes in the international markets where its top holdings, like Roche and Novartis, operate.

DTAN Top 10 Holdings

DTAN’s story is driven largely by big international health care names, with Roche and Novartis quietly rising and giving the fund a solid defensive backbone. Siemens and Airbus add an industrial tilt, with both showing generally positive momentum, helping keep the engine humming. On the flip side, AstraZeneca, Sanofi, and especially SAP have been lagging, acting like a bit of sand in the fund’s gears. With holdings spread across Europe and Japan and little U.S. exposure, this ETF leans into global, intangible-rich franchises rather than homegrown tech giants.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Roche Holding AG3.66%$786.41K$348.49B38.24%
73
Outperform
Novartis AG3.34%$719.09KCHF231.75B31.63%
80
Outperform
Siemens3.04%$654.16K€215.45B31.27%
74
Outperform
Toyota Motor2.88%$620.05K¥32.63T10.78%
80
Outperform
L'Oreal2.80%$601.49K€205.48B2.97%
71
Outperform
Shell (UK)2.68%$577.08K£187.43B26.98%
73
Outperform
SAP SE2.61%$562.03K€184.10B-31.77%
66
Neutral
AstraZeneca2.36%$507.68K$263.99B3.27%
80
Outperform
Sony2.33%$501.55K¥22.44T-10.18%
73
Outperform
Hitachi,Ltd.2.33%$500.66K¥23.82T15.27%
77
Outperform

DTAN Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
32.11
Positive
100DMA
31.50
Positive
200DMA
31.18
Positive
Market Momentum
MACD
0.37
Negative
RSI
68.62
Neutral
STOCH
61.52
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DTAN, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.24, equal to the 50-day MA of 32.11, and equal to the 200-day MA of 31.18, indicating a bullish trend. The MACD of 0.37 indicates Negative momentum. The RSI at 68.62 is Neutral, neither overbought nor oversold. The STOCH value of 61.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DTAN.

DTAN Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$21.58M0.55%
67
Neutral
$38.35M1.09%
67
Neutral
$25.18M0.54%
60
Neutral
$24.91M0.57%
69
Neutral
$18.03M0.59%
58
Neutral
$14.93M0.70%
60
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DTAN
Sparkline International Intangible Value ETF
33.47
5.72
20.61%
AADR
AdvisorShares Dorsey Wright ADR ETF
PJIO
PGIM Jennison International Opportunities ETF
MIVL
MFS Active International Value ETF
ESIM
Eventide International ETF
PZIV
Pzena International Value ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement